Goodwin Procter advised SWORD Health on the deal.SWORD Health announced its Series D financing. This brings the total primary and secondary transactions to more than $320 million…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
